Back to results
US 6,440,471 B2Granted
Plant proanthocyanidin extracts
AssigneeJLB, Inc.
InventorsEdward B. Walker, Richard A. Mickelsen, Jr., Jennifer N. Mickelsen
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeJLB, Inc.
InventorsEdward B. Walker, Richard A. Mickelsen, Jr., Jennifer N. Mickelsen
Estimating the term…
Compounds isolated from plant materials, particularly plants of the genus Vaccinium, which have biological activity measurable as inhibition with adhesion of bacterial cells to surfaces, and an extract of such plant materials which is significantly enriched for the anti-adhesion activity. The specific compounds include procyanidins (also known as “condensed tannins”), leukocyanin, leucodelphinin, flavonol glucosides including myricetin-3-pyranoside and proanthocyanidin extracts. These proanthocyanidin extracts are capable of inhibiting agglutination reactions of P-type E. coli. The extracts containing proanthocyanidins contain at least one A-type interflavanoid bond. Methods of making an extract. Methods of preventing or treating urogenital infections in a mammal by administering a proanthocyanidin composition including the proanthocyanidin extract, a proanthocyanidin compound, a proanthocyanidin polymer or a mixture thereof, to a subjecct in an amount and for a time sufficient to prevent, reduce or eliminate symptoms associated with such infections.
A method of preventing or treating a urogenital infection in a mammal comprising administering an effective amount of a pharmaceutical composition having a peak located at about 95 ppm on a 13C NMR, said composition consisting essentially of proanthocyanidin compounds having an average of from at least four to about seven epicatechin flavanoid units, wherein at least two of said units are linked together by an A-type interflavanoid linkage by bonds between C4 and C8 and between the C2 and the oxygen of C7 of the units and the remainder of the units are linked to each other by a B-type interflavanoid bond between C4 and C8 or between C4 and C6 of the units, wherein said composition is admixed with a pharmaceutically acceptable carrier.
A method of preventing or treating a urinary tract infection in a mammal comprising administering a pharmaceutical composition to said mammal in an amount and for a time sufficient to prevent, reduce or eliminate symptoms associated with said infection, wherein said pharmaceutical composition comprises a pharmaceutically-acceptable carrier in admixture with a proanthocyanidin extract having a peak located at about 95 ppm on a 13C NMR, said extract consisting essentially of proanthocyanidin compounds having an average of from at least four to about seven epicatechin flavanoid units, wherein at least two of said units are linked together by an A-type interflavanoid linkage by bonds between C4 and C8 and between the C2 and the oxygen of C7 of the units and the remainder of the units are linked to each other by a B-type interflavanoid bond between C4 and C8 or between C4 and C6 of the units.
A method of preventing or treating a urogenital infection in a livestock animal comprising administering an effective amount of a food composition comprising an animal feed in admixture with a proanthocyanidin extract having a peak located at about 95 ppm on a 13C NMR, said extract consisting essentially of proanthocyanidin compounds having an average of from at least four to about seven epicatechin flavanoid units, wherein at least two of said units are linked together by an A-type interflavanoid linkage by bonds between C4 and C8 and between the C2 and the oxygen of C7 of the units and the remainder of the units are linked to each other by a B-type interflavanoid bond between C4 and C8 or between C4 and C6 of the units.
A method of preventing or treating a urogenital infection in a domesticated animal comprising administering an effective amount of a food composition to said animal wherein said composition comprises an animal feed in admixture with a proanthocyanidin extract having a peak located at about 95 ppm on a 13C NMR, said extract consisting essentially of proanthocyanidin compounds having an average of from at least four to about seven epicatechin flavanoid units, wherein at least two of said units are linked together by an A-type interflavanoid linkage by bonds between C4 and C8 and between the C2 and the oxygen of C7 of the units and the remainder of the units are linked to each other by a B-type interflavanoid bond between C4 and C8 or between C4 and C6 of the units.
Dependencies are inferred from the claim text.